Literature DB >> 2688754

Chronic lymphocytic leukaemia: when and how to treat.

C Rozman1, E Montserrat.   

Abstract

In the 4th International Workshop on Chronic Lymphocytic Leukaemia (CLL), staging and response criteria were proposed to help physicians make decisions on when and how to treat patients with CLL. The most important factor is prolonging survival. There are several promising new treatment approaches under investigation, and the criteria proposed should facilitate future therapy trials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688754     DOI: 10.1007/bf00329491

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  47 in total

1.  Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial.

Authors:  Robert Peter Gale; Helen M Chapel; Christopher Bunch; Kanti R Rai; Kenneth Foon; Suzanne G Courter; Dierdre Tait
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

2.  Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.

Authors:  M R Grever; K J Kopecky; C A Coltman; J C Files; B R Greenberg; J J Hutton; R Talley; D D Von Hoff; S P Balcerzak
Journal:  Nouv Rev Fr Hematol       Date:  1988

3.  Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation.

Authors:  C Shustik; R Mick; R Silver; A Sawitsky; K Rai; L Shapiro
Journal:  Hematol Oncol       Date:  1988 Jan-Mar       Impact factor: 5.271

4.  Splenectomy in advanced chronic lymphocytic leukemia.

Authors:  A Ferrant; J L Michaux; G Sokal
Journal:  Cancer       Date:  1986-11-01       Impact factor: 6.860

5.  Prognostic factors in chronic lymphocytic leukemia.

Authors:  K R Rai; E Montserrat
Journal:  Semin Hematol       Date:  1987-10       Impact factor: 3.851

6.  Treatment of chronic lymphocytic leukemia by total body irradiation alone and combined with chemotherapy.

Authors:  R E Johnson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-02       Impact factor: 7.038

7.  Comparison of the (A, B, C) staging and the Rai's staging from a large prospective series (935 patients). French Cooperative Group on Chronic Lymphocytic Leukemia.

Authors: 
Journal:  Nouv Rev Fr Hematol       Date:  1988

Review 8.  Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).

Authors:  S Kempin; B J Lee; H T Thaler; B Koziner; S Hecht; T Gee; Z Arlin; C Little; D Straus; L Reich; E Phillips; H Al-Mondhiry; M Dowling; K Mayer; B Clarkson
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

9.  An uncontrolled clinical trial--treatment response or spontaneous improvement?

Authors:  N Mantel
Journal:  Control Clin Trials       Date:  1982-12

10.  Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.

Authors:  E Montserrat; N Viñolas; J C Reverter; C Rozman
Journal:  Nouv Rev Fr Hematol       Date:  1988
View more
  1 in total

1.  Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.

Authors:  E Montserrat; N Villamor; A Urbano-Ispizua; J M Ribera; M Lozano; J L Vives-Corrons; C Rozman
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.